Predictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.

Basit Öğe Kaydı
dc.contributor.authorAkarca, US
dc.contributor.authorSayiner, A
dc.contributor.authorErsoz, G
dc.contributor.authorGunsar, F
dc.contributor.authorOzacar, T
dc.contributor.authorBatur, Y
dc.date.accessioned2019-10-27T18:24:55Z
dc.date.available2019-10-27T18:24:55Z
dc.date.issued1999
dc.departmentEge Üniversitesien_US
dc.identifier.endpage631Aen_US
dc.identifier.issn0270-9139
dc.identifier.issue4en_US
dc.identifier.startpage631Aen_US
dc.identifier.urihttps://hdl.handle.net/11454/36250
dc.identifier.volume30en_US
dc.identifier.wosWOS:000082794701878en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherW B Saunders Coen_US
dc.relation.ispartofHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePredictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu